The Flow and Image Cytometry Resource provides advanced flow cytometric and morphology service at the light and electron microscope (EM) levels of resolution utilizing state-of-the-art technology and an extensive computer network that has been assembled into a user-friendly environment. The Resource is supervised by Paul K. Wallace, PhD, and Hans Minderman, PhD, and is staffed by five technical personnel. The goal is to provide (i) multiparameter flow cytometry, encompassing analytical, sorting and Luminex services, (ii) morphological services at the light and EM levels of resolution, and (iii) instruction and technical support as required by investigators. As a focal point for many interdisciplinary activities throughout RPCI, the Resource supports both basic research and clinical protocol services. The Resource has an extensive immunophenotyping service and is the core flow cytometric laboratory for many NIH-initiated national clinical trials. The Flow Cytometry Component of the Resource offers both clinical and basic research support services, which universally maintain a quality assurance program using guidelines from state and national accrediting agencies. The Imaging Component enables qualitative and quantitative image analysis on the tissue, cellular and subcellular levels, time-kinetic multicolor image analysis and quantitative multispectral image analysis. The Educational Program Component provides didactic lectures and hands-on experience with (i) isolation, preparation, and staining of all types of human and animal cells, (ii) instrument setup and acquisition, and (iii) data analysis, The Resource has complete general biology, tissue culture, optics and electronics, and computer laboratories, as well as a fabrication shop. The Resource's strategic plan emphasizes the provision of stateof- the-art technology and expertise in all facets of flow and image cytometry, and supporting the needs of CCSG Program members to enhance peer-reviewed funding and publications. During the reporting period (4/1/06 to 3/31/07), the Resource contributed to the research of 67 investigators from all six CCSG Programs, with 85% of Resource utilization by CCSG Program members with peer-reviewed funding. $110,245 in CCSG support is requested, representing 8% of the total operating budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016056-36
Application #
8375974
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
2014-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
36
Fiscal Year
2012
Total Cost
$232,585
Indirect Cost
$92,070
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Mahoney, Martin C; Erwin, Deborah O; Twarozek, Annamaria Masucci et al. (2018) Leveraging technology to promote smoking cessation in urban and rural primary care medical offices. Prev Med 114:102-106
Cheng, Ting-Yuan David; Darke, Amy K; Redman, Mary W et al. (2018) Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424). J Natl Cancer Inst 110:734-742
Zonneville, Justin; Safina, Alfiya; Truskinovsky, Alexander M et al. (2018) TGF-? signaling promotes tumor vasculature by enhancing the pericyte-endothelium association. BMC Cancer 18:670
Rabi, Thangaiyan; Li, Fengzhi (2018) Multiple mechanisms involved in a low concentration of FL118 enhancement of AMR-MeOAc to induce pancreatic cancer cell apoptosis and growth inhibition. Am J Cancer Res 8:2267-2283
Haring, Rodney C; Henry, Whitney Ann; Hudson, Maui et al. (2018) Views on clinical trial recruitment, biospecimen collection, and cancer research: population science from landscapes of the Haudenosaunee (People of the Longhouse). J Cancer Educ 33:44-51
Elahi, Seerat; Egan, Shawn M; Holling, G Aaron et al. (2018) The RNA binding protein Ars2 supports hematopoiesis at multiple levels. Exp Hematol 64:45-58.e9
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :

Showing the most recent 10 out of 1555 publications